Results 251 to 260 of about 1,505,630 (287)
The present invention is directed to a nucleic acid molecule comprising a polynucleotide sequence encoding a chimeric antigen receptor comprising (a) an anti-CLEC14A binding domain, (b) a transmembrane domain and (c) an intracellular signalling domain ...
ONUOHA SHIMOBI +4 more
core +8 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Chimeric Antigen Receptor beyond CAR-T Cells
Cancers, 2021Paul Neeson, Criselle Dsouza, Joe Zhu
exaly
A review of cancer immunotherapy toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Kennedy
exaly

